Suspected neurological toxicity after oral application of fluralaner (Bravecto®) in a Kooikerhondje dog

Suspected neurological toxicity after oral application of fluralaner (Bravecto®) in a Kooikerhondje dog

Abstract Background Although the new isoxazoline drug fluralaner (Bravecto®) is generally well tolerated in dogs, adverse drug reactions involving neurological dysfunction occurred in individual dogs. However, most of these cases are documented inadequately and none of them is reported and discussed...

Full description

Bibliographic Details
Main Authors: Daniela Gaens, Christoph Rummel, Martin Schmidt, Melanie Hamann, Joachim Geyer
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Veterinary Research
Subjects:
Bravecto
Fluralaner
Dog
Adverse drug reaction
Neurological toxicity
MDR1 mutation
Online Access:http://link.springer.com/article/10.1186/s12917-019-2016-4

Internet

http://link.springer.com/article/10.1186/s12917-019-2016-4

Similar Items